| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aggressive bowel lymphoma in a patient with intestinal lymphangiectasia and widespread viral warts
|
Gumà, J.
|
|
|
9 |
12 |
p. 1355-1356
|
article
|
| 2 |
Aggressive bowel lymphoma in a patient with intestinal lymphangiectasiaand widespread viral warts
|
J. Gumà
|
|
1998
|
9 |
12 |
p. 1355-1356
2 p.
|
article
|
| 3 |
A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer
|
Friedlander, M.
|
|
|
9 |
12 |
p. 1343-1345
|
article
|
| 4 |
A phase II study of gemcitabine in platinum pre-treated patients withadvanced epithelial ovarian cancer
|
M. Friedlander
|
|
1998
|
9 |
12 |
p. 1343-1345
3 p.
|
article
|
| 5 |
Author Index
|
|
|
1998
|
9 |
12 |
p. 1375-1383
9 p.
|
article
|
| 6 |
Awards, appointments
|
|
|
|
9 |
12 |
p. 1259-1260
|
article
|
| 7 |
B. B. Mittal, J. A. Purdy, K. K. Ang (eds)., Advances in radiation therapy.
|
J. Bernier
|
|
1998
|
9 |
12 |
p. 1268-1268
1 p.
|
article
|
| 8 |
Book review
|
Bernier, J.
|
|
|
9 |
12 |
p. 1268
|
article
|
| 9 |
Book review
|
Alerci, M.
|
|
|
9 |
12 |
p. 1262
|
article
|
| 10 |
Cancer targets unmet, while life expectancy falls in Europe
|
|
|
|
9 |
12 |
p. 1258
|
article
|
| 11 |
Chylopericardium of neoplastic aetiology
|
Andrade Santiago, J.
|
|
|
9 |
12 |
p. 1339-1342
|
article
|
| 12 |
Chylopericardium of neoplastic aetiology
|
J. Andrade Santiago
|
|
1998
|
9 |
12 |
p. 1339-1342
4 p.
|
article
|
| 13 |
Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients
|
Weijl, N.I.
|
|
|
9 |
12 |
p. 1331-1337
|
article
|
| 14 |
Clinical and pharmacologic phase I study of Cemadotin–HCl* * Recommended International Nonproprietory Name (INN). (LU103793), a novel antimitotic peptide, given as 24-hour infusion in patients with advanced cancer
|
Mross, K.
|
|
|
9 |
12 |
p. 1323-1330
|
article
|
| 15 |
Contents of the next issue
|
|
|
|
9 |
12 |
p. v
|
article
|
| 16 |
Copyright
|
|
|
|
9 |
12 |
p. iii
|
article
|
| 17 |
D. B. Kopans (ed)., Breast imaging.
|
M. Alerci
|
|
1998
|
9 |
12 |
p. 1262-1262
1 p.
|
article
|
| 18 |
Divergent illicit drug policies in Europe
|
|
|
|
9 |
12 |
p. 1257
|
article
|
| 19 |
Divergent illicit drug policies in Europe; Partial consensus about breastand cancer treatment in Florence; Cancer targets unmet, while life expectancyfalls in Europe; What about euthanasia and palliative care in Europe?; Awards,appointments; WHO in search of cancer strategies for the new millennium;Perhaps not everyone knows that...
|
|
|
1998
|
9 |
12 |
p. 1257-1261
5 p.
|
article
|
| 20 |
Editorial board
|
|
|
|
9 |
12 |
p. iv
|
article
|
| 21 |
Gemcitabine – a major advance?
|
Thomas, A.
|
|
|
9 |
12 |
p. 1265-1267
|
article
|
| 22 |
Gemcitabine a major advance?
|
A. Thomas
|
|
1998
|
9 |
12 |
p. 1265-1267
3 p.
|
article
|
| 23 |
Hemolytic-uremic syndrome caused by gemcitabine
|
Nackaerts, K.
|
|
|
9 |
12 |
p. 1355
|
article
|
| 24 |
Hemolytic-uremic syndrome caused by gemcitabine
|
K. Nackaerts
|
|
1998
|
9 |
12 |
p. 1355-1355
1 p.
|
article
|
| 25 |
Index of authors Volume 9 (1998)
|
|
|
|
9 |
12 |
p. 1375-1383
|
article
|
| 26 |
Index of subjects Volume 9 (1998)
|
|
|
|
9 |
12 |
p. 1357-1374
|
article
|
| 27 |
In this Issue
|
|
|
|
9 |
12 |
p. v
|
article
|
| 28 |
Long-term results from a phase II study of single agent paclitaxel (Taxol®) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience
|
Tropé, C.
|
|
|
9 |
12 |
p. 1301-1307
|
article
|
| 29 |
5-Methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: A randomized phase I–II study of two different FU administration schedules
|
Hejna, M.
|
|
|
9 |
12 |
p. 1309-1314
|
article
|
| 30 |
5-Methyltetrahydrofolate for biochemical modulation of fluorouracil (FU)in patients with advanced colorectal cancer: A randomized phase IIIstudy of two different FU administration schedules
|
M. Hejna
|
|
1998
|
9 |
12 |
p. 1309-1314
6 p.
|
article
|
| 31 |
Overdiagnosis of prostate carcinoma by screening: An estimate based on the results of the Florence Screening Pilot Study
|
Zappa, M.
|
|
|
9 |
12 |
p. 1297-1300
|
article
|
| 32 |
Partial consensus about breast and cancer treatment in Florence
|
|
|
|
9 |
12 |
p. 1257
|
article
|
| 33 |
Perhaps not everyone knows that…
|
|
|
|
9 |
12 |
p. 1260-1261
|
article
|
| 34 |
Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days
|
Sessa, C.
|
|
|
9 |
12 |
p. 1315-1322
|
article
|
| 35 |
Phase I clinical and pharmacokinetic study of the oral platinum analogueJM216 given daily for 14 days
|
C. Sessa
|
|
1998
|
9 |
12 |
p. 1315-1322
8 p.
|
article
|
| 36 |
Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck
|
Hitt, R.
|
|
|
9 |
12 |
p. 1347-1349
|
article
|
| 37 |
Prostate specific antigen (PSA) testing as screening for prostate cancer: The current controversy
|
Boyle, P.
|
|
|
9 |
12 |
p. 1263-1264
|
article
|
| 38 |
Prostate specific antigen (PSA) testing as screening for prostate cancer:The current controversy
|
P. Boyle
|
|
1998
|
9 |
12 |
p. 1263-1264
2 p.
|
article
|
| 39 |
PSA screening current controversy
|
D. Svetec
|
|
1998
|
9 |
12 |
p. 1283-1288
6 p.
|
article
|
| 40 |
PSA screening – current controversy* * The opinions or assertions contained herein are the private views of the authors and are not to be construed as reflecting the views of the Departments of the Army, the Air Force or Defense. , † † The US Government’s right to retain a non-exclusive, royalty-free licence in and to any copyright is acknowledged.
|
Svetec, D.
|
|
|
9 |
12 |
p. 1283-1288
|
article
|
| 41 |
PSA screening for prostate cancer: The current controversy
|
de Koning, H.J.
|
|
|
9 |
12 |
p. 1293-1296
|
article
|
| 42 |
PSA screening for prostate cancer: The current controversy
|
H. J. de Koning
|
|
1998
|
9 |
12 |
p. 1293-1296
4 p.
|
article
|
| 43 |
PSA screening for prostate cancer: The current controversy – a viewpoint
|
Barry, M.J.
|
|
|
9 |
12 |
p. 1279-1282
|
article
|
| 44 |
PSA screening for prostate cancer: The current controversy aviewpoint
|
M. J. Barry
|
|
1998
|
9 |
12 |
p. 1277-1282
6 p.
|
article
|
| 45 |
Screening for prostate cancer
|
Neal, D.E.
|
|
|
9 |
12 |
p. 1289-1292
|
article
|
| 46 |
Screening for prostate cancer
|
D. E. Neal
|
|
1998
|
9 |
12 |
p. 1289-1292
4 p.
|
article
|
| 47 |
Subject Index
|
|
|
1998
|
9 |
12 |
p. 1357-1374
18 p.
|
article
|
| 48 |
Table of Contents
|
|
|
|
9 |
12 |
p. ii-iii
|
article
|
| 49 |
The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: Use, limitations and future of RNA-based methods
|
Lambrechts, A.C.
|
|
|
9 |
12 |
p. 1269-1276
|
article
|
| 50 |
Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients
|
Zinzani, P.L.
|
|
|
9 |
12 |
p. 1351-1353
|
article
|
| 51 |
Therapy with gemcitabine in pretreated peripheral T-cell lymphomapatients
|
P. L. Zinzani
|
|
1998
|
9 |
12 |
p. 1351-1353
3 p.
|
article
|
| 52 |
What about euthanasia and palliative care in Europe?
|
|
|
|
9 |
12 |
p. 1258
|
article
|
| 53 |
WHO in search of cancer strategies for the new millennium
|
|
|
|
9 |
12 |
p. 1258-1259
|
article
|
Journal description